AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase (EC 2.3.1.82) of the GNAT acetyltransferase superfamily. It transfers an acetyl group from acetyl-CoA to the 6'-amino group of 4,6-disubstituted aminoglycosides (e.g. kanamycin, amikacin, tobramycin, netilmicin), abolishing their binding to the 16S rRNA A-site and conferring aminoglycoside resistance by drug inactivation. AAC(6')-Ib is the most prevalent aminoglycoside acetyltransferase in Gram-negative clinical isolates and is typically carried as a gene cassette in class 1 integrons on plasmids; numbered allelic variants (here -Ib8) differ by point substitutions.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0016407
acetyltransferase activity
|
IEA
GO_REF:0000104 |
MODIFY |
Summary: Correct but over-general. The specific characterised activity is aminoglycoside 6'-N-acetyltransferase activity (GO:0047663, EC 2.3.1.82), which is already annotated.
Reason: Over-general parent of the specific GO:0047663 already present on this entry; the specific term should be used.
Proposed replacements:
aminoglycoside 6'-N-acetyltransferase activity
|
|
GO:0016740
transferase activity
|
IEA
GO_REF:0000104 |
MODIFY |
Summary: Root-level transferase term derived from the UniProt 'Transferase' keyword; uninformative given the specific GO:0047663 annotation.
Reason: Far too general (keyword-derived); subsumed by the specific aminoglycoside 6'-N-acetyltransferase activity.
Proposed replacements:
aminoglycoside 6'-N-acetyltransferase activity
|
|
GO:0016747
acyltransferase activity, transferring groups other than amino-acyl groups
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: Correct but over-general (InterPro-derived); the specific 6'-N-acetyltransferase activity is the appropriate molecular function.
Reason: Over-general parent; replace with GO:0047663.
Proposed replacements:
aminoglycoside 6'-N-acetyltransferase activity
|
|
GO:0046677
response to antibiotic
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: AAC(6')-Ib8 confers aminoglycoside resistance by acetylating (inactivating) the drug; 'response to antibiotic' is the appropriate biological process for a resistance enzyme.
Reason: Standard, well-supported BP for an antibiotic-modifying resistance enzyme; consistent with the CARD 'antibiotic inactivation' mechanism for ARO:3002579.
Supporting Evidence:
PMID:18710261
Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides.
|
|
GO:0047663
aminoglycoside 6'-N-acetyltransferase activity
|
IEA
GO_REF:0000003 |
ACCEPT |
Summary: The specific, correct molecular function (EC 2.3.1.82): acetyl-CoA-dependent acetylation of the 6'-amino group of aminoglycosides (e.g. kanamycin B -> N(6')-acetylkanamycin B). This is the core function and exactly matches the EC and CARD AAC(6')-Ib family assignment.
Reason: EC 2.3.1.82-derived specific MF, consistent with the UniProt catalytic-activity reaction (kanamycin B + acetyl-CoA = N(6')-acetylkanamycin B + CoA), the AAC(6')-Ib family (CARD ARO:3002579), and the InterPro N6_acetyl_AAC6 signature (IPR030971). Retain as the core function.
Supporting Evidence:
PMID:18710261
Observation of the direct, and optimally positioned, interaction between the 6'-NH
|
|
GO:0005737
cytoplasm
|
IDA
PMID:18710261 Mechanistic and structural analysis of aminoglycoside N-acet... |
NEW |
Summary: AAC(6')-Ib is a soluble GCN5-related N-acetyltransferase (GNAT) that uses cytoplasmic acetyl-CoA; it was expressed and purified as a soluble enzyme and structurally characterized. The expected cellular location is the cytoplasm; GOA carried no location term.
Reason: Soluble cytoplasmic acetyltransferase using the cytoplasmic cofactor acetyl-CoA; adding the cellular component makes the annotation set complete.
Supporting Evidence:
PMID:18710261
The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2
|
Q: Does AAC(6')-Ib8 carry any of the substitutions (e.g. Trp102Arg/Asp179Tyr) that, in the AAC(6')-Ib-cr variant, extend activity to fluoroquinolones, or is it a 'classical' aminoglycoside-only enzyme?
Experiment: Determine acetylation kinetics (kcat/Km) against a panel of 4,6-aminoglycosides (kanamycin, amikacin, tobramycin, netilmicin) with acetyl-CoA, and test ciprofloxacin to exclude AAC(6')-Ib-cr activity.
id: A0A076UB44
gene_symbol: aac6-Ib
aliases:
- "AAC(6')-Ib8"
- "AAC(6')-I"
- Aminoglycoside N(6')-acetyltransferase type 1
product_type: PROTEIN
status: DRAFT
taxon:
id: NCBITaxon:550
label: Enterobacter cloacae
description: >-
AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase (EC 2.3.1.82) of the GNAT acetyltransferase
superfamily. It transfers an acetyl group from acetyl-CoA to the 6'-amino group of 4,6-disubstituted
aminoglycosides (e.g. kanamycin, amikacin, tobramycin, netilmicin), abolishing their binding to the
16S rRNA A-site and conferring aminoglycoside resistance by drug inactivation. AAC(6')-Ib is the most
prevalent aminoglycoside acetyltransferase in Gram-negative clinical isolates and is typically carried
as a gene cassette in class 1 integrons on plasmids; numbered allelic variants (here -Ib8) differ by
point substitutions.
references:
- id: PMID:18710261
title: "Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant."
findings:
- statement: >-
AAC(6')-Ib is a regioselective aminoglycoside N-acetyltransferase; such enzymes are the
predominant cause of bacterial aminoglycoside resistance. It acetylates the 6'-amino group, with
Asp115 acting as the general base.
supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
- statement: >-
AAC(6')-Ib-wt was expressed and purified as a soluble protein and its three-dimensional structure
solved in complex with donor (CoA) and acceptor (aminoglycoside) ligands, defining the catalytic
mechanism.
supporting_text: "The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified (Vetting et al., Biochemistry 2008; PMC2855648, full text). Kinetic and structural
characterization of AAC(6')-Ib (and the -cr variant); directly supports the 6'-N-acetyltransferase
activity and the soluble GNAT-fold enzyme.
- id: PMID:16369542
title: "Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase."
findings:
- statement: >-
A variant of AAC(6')-Ib (AAC(6')-Ib-cr, bearing Trp102Arg and Asp179Tyr) acquires the ability to
N-acetylate fluoroquinolones (ciprofloxacin), reducing their activity.
supporting_text: "ciprofloxacin in clinical bacterial isolates conferred by a variant of the gene encoding aminoglycoside acetyltransferase AAC(6')-Ib"
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
PubMed-verified (Robicsek et al., Nat Med 2006). Describes the AAC(6')-Ib-cr fluoroquinolone-active
variant; relevant to whether this allele (-Ib8) is a classical aminoglycoside-only enzyme.
- id: GO_REF:0000002
title: "Gene Ontology annotation through association of InterPro records with GO terms"
findings: []
- id: GO_REF:0000003
title: "Gene Ontology annotation based on Enzyme Commission mapping"
findings: []
- id: GO_REF:0000104
title: "Gene Ontology annotation by UniProt keywords"
findings: []
- id: GO_REF:0000117
title: "Electronic Gene Ontology annotations created by ARBA machine learning models"
findings: []
existing_annotations:
- term:
id: GO:0016407
label: acetyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000104
qualifier: enables
review:
summary: >-
Correct but over-general. The specific characterised activity is aminoglycoside
6'-N-acetyltransferase activity (GO:0047663, EC 2.3.1.82), which is already annotated.
action: MODIFY
reason: >-
Over-general parent of the specific GO:0047663 already present on this entry; the specific term
should be used.
proposed_replacement_terms:
- id: GO:0047663
label: aminoglycoside 6'-N-acetyltransferase activity
- term:
id: GO:0016740
label: transferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000104
qualifier: enables
review:
summary: >-
Root-level transferase term derived from the UniProt 'Transferase' keyword; uninformative given
the specific GO:0047663 annotation.
action: MODIFY
reason: >-
Far too general (keyword-derived); subsumed by the specific aminoglycoside 6'-N-acetyltransferase
activity.
proposed_replacement_terms:
- id: GO:0047663
label: aminoglycoside 6'-N-acetyltransferase activity
- term:
id: GO:0016747
label: acyltransferase activity, transferring groups other than amino-acyl groups
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Correct but over-general (InterPro-derived); the specific 6'-N-acetyltransferase activity is the
appropriate molecular function.
action: MODIFY
reason: >-
Over-general parent; replace with GO:0047663.
proposed_replacement_terms:
- id: GO:0047663
label: aminoglycoside 6'-N-acetyltransferase activity
- term:
id: GO:0046677
label: response to antibiotic
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
AAC(6')-Ib8 confers aminoglycoside resistance by acetylating (inactivating) the drug; 'response
to antibiotic' is the appropriate biological process for a resistance enzyme.
action: ACCEPT
reason: >-
Standard, well-supported BP for an antibiotic-modifying resistance enzyme; consistent with the
CARD 'antibiotic inactivation' mechanism for ARO:3002579.
supported_by:
- reference_id: PMID:18710261
supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
- term:
id: GO:0047663
label: aminoglycoside 6'-N-acetyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000003
qualifier: enables
review:
summary: >-
The specific, correct molecular function (EC 2.3.1.82): acetyl-CoA-dependent acetylation of the
6'-amino group of aminoglycosides (e.g. kanamycin B -> N(6')-acetylkanamycin B). This is the core
function and exactly matches the EC and CARD AAC(6')-Ib family assignment.
action: ACCEPT
reason: >-
EC 2.3.1.82-derived specific MF, consistent with the UniProt catalytic-activity reaction
(kanamycin B + acetyl-CoA = N(6')-acetylkanamycin B + CoA), the AAC(6')-Ib family (CARD
ARO:3002579), and the InterPro N6_acetyl_AAC6 signature (IPR030971). Retain as the core function.
supported_by:
- reference_id: PMID:18710261
supporting_text: "Observation of the direct, and optimally positioned, interaction between the 6'-NH"
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:18710261
qualifier: located_in
review:
summary: >-
AAC(6')-Ib is a soluble GCN5-related N-acetyltransferase (GNAT) that uses cytoplasmic acetyl-CoA;
it was expressed and purified as a soluble enzyme and structurally characterized. The expected
cellular location is the cytoplasm; GOA carried no location term.
action: NEW
reason: >-
Soluble cytoplasmic acetyltransferase using the cytoplasmic cofactor acetyl-CoA; adding the
cellular component makes the annotation set complete.
supported_by:
- reference_id: PMID:18710261
supporting_text: "The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2"
core_functions:
- description: >-
AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase: it transfers an acetyl group from
acetyl-CoA to the 6'-amino group of 4,6-disubstituted aminoglycosides, inactivating the drug and
conferring aminoglycoside resistance.
molecular_function:
id: GO:0047663
label: aminoglycoside 6'-N-acetyltransferase activity
directly_involved_in:
- id: GO:0046677
label: response to antibiotic
locations:
- id: GO:0005737
label: cytoplasm
substrates:
- id: CHEBI:57288
label: acetyl-CoA
supported_by:
- reference_id: PMID:18710261
supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
# CURATION NOTE (ARO->GO mapping QA): the ARO->GO mapping (ARO:3000121 'aminoglycoside acetyltransferase
# (AAC)' -> GO:0034069 'aminoglycoside N-acetyltransferase activity') would propose GO:0034069 for this
# entry. It is intentionally NOT added: GO:0034069 is the is_a PARENT of the existing, more specific
# GO:0047663 and would be a redundant over-annotation. This is the subsumption case flagged in the
# project spot review (the gain report should suppress a candidate when a more specific descendant is
# already annotated).
suggested_questions:
- question: >-
Does AAC(6')-Ib8 carry any of the substitutions (e.g. Trp102Arg/Asp179Tyr) that, in the AAC(6')-Ib-cr
variant, extend activity to fluoroquinolones, or is it a 'classical' aminoglycoside-only enzyme?
suggested_experiments:
- description: >-
Determine acetylation kinetics (kcat/Km) against a panel of 4,6-aminoglycosides (kanamycin,
amikacin, tobramycin, netilmicin) with acetyl-CoA, and test ciprofloxacin to exclude AAC(6')-Ib-cr
activity.